Pictet Asset Management (UK)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-611,356
| Closed | -$6.57M | – | 1005 |
|
|
2019
Q1 | $6.57M | Buy |
611,356
+5,670
| +0.9% | +$61K | 0.01% | 623 |
|
|
2018
Q4 | $9.15K | Sell |
605,686
-11,523
| -2% | -$174 | 0.02% | 511 |
|
|
2018
Q3 | $11.4M | Buy |
617,209
+92,725
| +18% | +$1.72M | 0.02% | 521 |
|
|
2018
Q2 | $12M | Buy |
524,484
+51,535
| +11% | +$1.18M | 0.03% | 480 |
|
|
2018
Q1 | $13.5M | Sell |
472,949
-113,663
| -19% | -$3.23M | 0.03% | 451 |
|
|
2017
Q4 | $12.4M | Buy |
+586,612
| New | +$12.4M | 0.03% | 465 |
|